DMC Docs First In U.S. To Use New Heart Pump During Artery RepairThe Detroit Medical Center announced that the hospital group's Cardiovascular Institute has conducted the nation's first artery-repair procedure using a new high-tech, catheter-delivered tool designed to pump up to four liters of blood per minute through a patient's circulatory system. The new device allows the heart to rest while repairs are made to damaged arteries.
DMC Cardiovascular Institute In New PAD Clinical TrialThe DMC Cardiovascular Institute announced Wednesday that it will participate in Connect II, a global clinical trial conditionally approved by the FDA that gives physicians access to Ocelot, a new imaging technology tool to fight Peripheral Arterial Disease.
DMC Cardiovascular Institute Physician is First in Michigan to Use New "Arterial Drill"The Detroit Medical Center Cardiovascular Institute has become the first cardiac care facility in Michigan to successfully open a patient's blocked artery with a breakthrough technology that operates like an electrically powered "corkscrew drill" to painlessly remove the plaque buildup which causes Peripheral Artery Disease.
DMC First in Midwest to Implant New "Protecta" DefibrillatorThe Detroit Medical Center Cardiovascular Institute announced that it has achieved a significant breakthrough in cardiac heart-care by implanting the newly available "Protecta" defibrillator in a heart-care patient.
DMC First In Michigan To Study New Heart Attack DeviceDetroit Medical Center Cardiovascular Institute announced its first implant of the AngelMed Guardian cardiac monitor and alert system, which warns patients of an impending heart attack and urges them to get to the ER.
DMC Michigan's First To Offer Breakthrough Technology To Correct Irregular HeartbeatThe DMC Cardiovascular Institute is the first in Michigan to offer a new breakthrough technology to correct atrial fibrillation.
DMC First In Michigan In Trial Of New Heart Valve ImplantThe Detroit Medical Center Cardiovascular Institute has completed the first two transcatheter aortic valve implants ever achieved in Michigan. The procedures are a part of the CVI's participation in the Medtronic CoreValve U.S. Clinical Trial. This multi-state trial will evaluate a new, non-surgical alternative to open-heart surgery for patients with severe aortic stenosis.